Regarding differences in PTEN expression among the glioma subtypes included in the study, most oligodendrogliomas showed high expression (14/19; 73.7%), while the majority of astrocytomas (9/13; 69.2%) showed a reduced or highly reduced PTEN protein expression (Table 2). This evidence concerns the gene PTEN and astrocytoma (excluding glioblastoma).